Background
==========

Mastitis, the inflammation of the mammary gland, is the most important disease of dairy cattle, with respect to the frequency of occurrence, animal welfare and economic cost, which is estimated to approach \$2 billion annually in the US alone (reviewed by \[[@B1]\]). Mastitis is most frequently caused by infection by a variety of bacteria, of which *Staphylococcus aureus* and *Escherichia coli* are amongst the most important gram-positive and gram-negative bacteria respectively (reviewed by \[[@B2]\]). There is considerable variation in the mastitic disease caused by these two pathogens. *E. coli* intramammary infections often result in acute mastitis with severe clinical manifestations, which usually resolves within a few days. In contrast, symptoms induced by *S. aureus* infection are usually less severe, even asymptomatic, and the infection can persist for long periods of time.

Current control strategies largely involve hygiene practices on the farm and the direct administration of antibiotics into udder quarters exhibiting clinical signs of infection. However, many infections are asymptomatic and there is a desire to minimize the use of antibiotics. Therefore, there is a need to develop new and improved control strategies. To achieve this goal our understanding of events that occur during infection must be improved. The use of global transcriptomic studies, either involving the use of microarrays or more recently Next Generation Sequencing, is ideally suited to investigate the complex host-pathogen interplay occurring during mastitis, by simultaneously quantifying the expression of thousands of genes. Several studies have used microarrays to investigate the bovine mammary gland response to infection with particular bacteria, including *E. coli*\[[@B3],[@B4]\], *Streptococcus uberis*\[[@B5],[@B6]\] and *S. aureus*\[[@B7]\]. A direct comparison of the induced transcriptional responses identified in these studies is difficult because of differences in the experimental design and the microarray platforms used. However, meta-analyses of such transcriptional studies have recently been reported \[[@B8],[@B9]\]. The meta-analysis reported by Genini et al. \[[@B8]\] identified a common transcriptional response in the mammary glands of several species to different pathogens and identified several new pathways not previously identified in the individual studies. However, a considerable amount of information was excluded from this meta-analysis because of the limited overlap of probes included on the microarrays used in the original studies. Therefore, we designed an infection study to investigate and compare the early transcriptional response of the bovine mammary gland to challenge with *S. aureus* and *E. coli* using a single microarray platform.

The experimental model used in this study involved the sequential inoculation of udder quarters with bacteria over the course of the study period, leaving one quarter uninfected as a within animal control \[[@B10]\]. The use of within animal controls is a common and accepted practice because the udder quarters are generally considered to be separate, independent anatomical structures \[[@B3]-[@B7],[@B11]-[@B16]\] and reduces the between animal variation seen in outbred species such as cattle, as well as addressing the 3Rs, Reduction, Replacement and Refinement, the principles behind the ethical framework for conducting animal experiments. However, analysis of the microarray experiment reported here revealed that *E. coli* infection of mammary gland quarters can have a profound effect on gene expression in other, uninfected quarters. This conclusion is supported by another transcriptional study comparing uninfected quarters from healthy and *E. coli* infected cattle \[[@B17]\]. Furthermore, analysis of the microarray data presented here suggests that a similar, but distinct, effect also occurs during *S. aureus* infection.

Results
=======

Microarray analysis of the transcriptional response of the bovine mammary gland to *E. coli* and *S. aureus* infection
----------------------------------------------------------------------------------------------------------------------

A strictly defined model for *E. coli*- and *S. aureus*-induced mastitis was developed involving the sequential infection of three udder quarters whilst the fourth quarter acted as a control \[[@B10]\]. RNA samples collected from each quarter of the twelve animals included in this study were interrogated using the ARK-Genomics *B. taurus* 20 K cDNA microarray. Initially, the intramammary transcriptional response to *E. coli* and *S. aureus* infection was investigated by comparing the expression of genes in infected quarters with those expressed in the uninfected, within animal control quarters. Only five clones exhibited differential expression during *S. aureus* infection (false discovery rate (*FDR)* ≤ 0.05, fold difference ≥ 2) (Table [1](#T1){ref-type="table"}). The clone AJ813772, which is currently unannotated and only matches EST sequences and an intergenic region of bovine chromosome 6, was significantly down-regulated 2.6 fold at 6 hours post infection. Similarly, two of the four clones that exhibit differential expression at 12 hours post infection are currently unannotated. These clones, AJ819694 and BF775518, were up-regulated 2.2 and 3.7 fold respectively. The other clones match lipopolysaccharide binding protein (LBP) and superoxide dismutase 2 (SOD2), which were up-regulated 4.8 and 5.9 fold respectively. No clones were identified as being differentially expressed at 24 or 72 hours post infection with *S. aureus*.

###### 

**Number of genes identified as being differentially expressed (*FDR*** **≤ 0.05, fold change ≥ 2) during*Escherichia coli*and*Staphylococcus aureus*infection by comparing samples to respective within-animal control samples**

   **Hours post infection**   ***E. coli***   ***S. aureus***
  -------------------------- --------------- -----------------
              6                     0                1
              12                    6                4
              24                  1048               0
              72                   \-                0

The *E. coli* infection induced clinical symptoms in cattle within 12 hours of infection, including; increased somatic cell count (SCC) in milk from infected quarters, decreased milk production, fever and decreased blood leukocyte counts \[[@B10]\]. It was, therefore, surprising that large numbers of differentially expressed genes were only detected in quarters infected for 24 hours (Table [1](#T1){ref-type="table"}). No clones exhibited differential expression at 6 hours post infection, whilst only six were differentially expressed at 12 hours post infection (*FDR* ≤ 0.05, fold difference ≥ 2). The currently unannotated clone C0882029 was down-regulated 2.1 fold. The remaining five clones were up-regulated and represent; chemokine (C-C motif) ligand 2 (3.9 fold), R3H domain containing 1 (3.3 fold), BTG family, member 2 (3.0 fold), Tribbles homolog 1 (2.4 fold) and chromosome 17 open reading frame 42 (2.3 fold). In contrast, 1048 clones were differentially expressed at 24 hours post infection. The two most up-regulated clones represent S100A8 and S100A12, which exhibited 21.9 and 19.8 fold up-regulation respectively. The two most down-regulated clones represent lipin 1 and WD repeat domain, phosphoinositide interacting 1 (WIPI1), which exhibited 5.4 and 5.2 fold down-regulation respectively.

Preliminary comparison of control quarters
------------------------------------------

The low numbers of differentially expressed genes (DEG) detected in infected udder quarters, especially those infected with *E. coli*, were unexpected. Recently over 70 genes were found to be differentially expressed in the bovine mammary gland 12 hours after *E. coli* infection \[[@B3]\]. Furthermore, 183 genes were found to be differentially expressed 16 hours post *S. aureus* infection of the bovine mammary gland \[[@B7]\] using the smaller bovine innate immune microarray \[[@B18]\]. The discrepancy between these results may relate to the strain of bacterium used or the tissue collection procedure. Another potential explanation is that the low number of DEG may be due to the base-line provided by the control quarters. To investigate this possibility the transcriptomes of the *E. coli* control quarters (EC24T0) and control quarters from both *S. aureus* infection experiments (SAT0) were compared. Preliminary analysis using GeneSpring (Agilent) highlighted differences between the transcription profiles. Log intensity plots (sample/reference) of EC24T0 and SAT0 had different shapes (Figure [1](#F1){ref-type="fig"}). Whilst both had normal type distributions centred around one, EC24T0 had a broader distribution than SAT0. This suggests that the transcription profile of SAT0 is more similar to the reference sample, a mixed pool of all the RNA samples, than EC24T0.

![**Differential expression in uninfected udder quarters from animals infected with*Escherichia coli*and*Staphylococcus aureus.***Preliminary analysis of the microarray data revealed different patterns of gene expression in control quarters from animals infected with *Escherichia coli*and *Staphylococcus aureus*. The log normalized intensity values (sample \[Cy5\]/reference \[Cy3\]) were plotted for the combined data from control quarters from animals infected with *E. coli*(EC24T0) and *S. aureus*(SAT0) using GeneSpring (Agilent). Both plots have a normal-type distribution around 1. EC24T0 have a broader peak of intensity values suggesting a greater range of expression compared to SAT0.](1471-2164-14-36-1){#F1}

Genes exhibiting differential expression in control quarters from animals infected with *E. coli* and *S. aureus*
-----------------------------------------------------------------------------------------------------------------

Due to the observed difference in the transcription profiles of RNA from the control quarters of *E. coli* and *S. aureus* infected animals, the transcriptomes of these samples were compared. Only the control quarters from the four animals infected with *S. aureus* for up to 24 hours (SA24T0) were included in this comparison. The analysis revealed that 255 clones exhibited significantly different expression levels in the control quarters (*FDR* ≤ 0.05, fold difference ≥ 2). The 255 clones, of which 212 are currently annotated, represent 187 genes and are listed in Additional file [1](#S1){ref-type="supplementary-material"}. Therefore, the uninfected quarters, which remained bacteriologically negative \[[@B10]\], exhibited significantly different transcriptional profiles, which were dependent on whether the animals had been infected in neighbouring quarters with *E. coli* or *S. aureus*. Ninety nine clones, representing 77 genes, were expressed at significantly higher levels in SA24T0 than in EC24T0. The clone AJ814393, which exhibited the highest expression level compared to EC24T0, a 4.6 fold difference, is currently unannotated, matching only EST sequences and an intergenic region of bovine chromosome 14. The remaining 156 clones, representing 110 genes, were expressed at significantly higher levels in EC24T0 than in SA24T0. The clone exhibiting the highest expression level compared to SA24T0, with a 6.6 fold difference, represents FK506 binding protein 5 (FKBP5).

The DEG list was examined using the web-based Database of Annotation, Visualization and Integrated Discovery (DAVID) \[[@B19],[@B20]\]. Human RefSeq accession numbers were used in the analysis due to the limitations in the current bovine annotation. Gene Ontology (GO) Biological Process classifications were assigned to 144 (77%) of the DEG. Gene enrichment analysis was carried out using the default human background and the probability of each functional category was calculated using the modified Fisher Extract test. The two GO terms exhibiting the greatest enrichment were; Cellular Compartment Organization and Biogenesis and Response to Stress (Table [2](#T2){ref-type="table"}). Other enriched GO terms included Cell Death and Cell Activation (Table [2](#T2){ref-type="table"}). These results indicate that a large cellular response to the infection of neighbouring quarters was occurring in EC24T0 and/or SA24T0.

###### 

**Major gene ontology biological process classifications represented by genes differentially expressed between control quarters from cows infected with*E. coli*(EC24T0) and*S. aureus*(SA24T0)**

                **Clone accession No.**                 **Gene symbol**  **Gene**                                                                                      **Fold difference**
  ---------------------------------------------------- ----------------- -------------------------------------------------------------------------------------------- ---------------------
   **CELLULAR COMPONENT ORGANIZATION AND BIOGENESIS**                                                                                                                 
                  **EC24T0 \> SA24T0**                                                                                                                                
                        AM017607                            ARPC5L       actin related protein 2/3 complex, subunit 5-like                                                    2.52
                        CN821828                              AGT        angiotensinogen                                                                                      3.73
                        AM034974                             BZW2        basic leucine zipper and W2 domains 2                                                                2.48
                        BG693016                             BTG1        B-cell translocation gene 1, anti-proliferative                                                      2.67
                        BF076579                              BAX        BCL2-associated X protein                                                                            2.02
                        AJ818096                             CEBPG       CCAAT/enhancer binding protein (C/EBP), gamma                                                        2.19
                        CO888526                             EMP1        epithelial membrane protein 1                                                                        2.30
                        CN824732                             EIF1        eukaryotic translation initiation factor 1                                                           2.08
                        CO894798                             EIF1B       eukaryotic translation initiation factor 1B                                                          2.03
                        CO888678                             EIF3D       eukaryotic translation initiation factor 3, subunit D                                                2.03
                        AJ691100                            EIF4A2       eukaryotic translation initiation factor 4A, isoform 2                                               2.52
                        CN823782                           GABARAPL1     GABA(A) receptor-associated protein like 1                                                           3.10
                        AJ818246                             HSPD1       heat shock 60 kDa protein 1                                                                          2.34
                        AJ673268                           HIST1H2AC     histone cluster 1, H2ac                                                                              3.30
                        CO884622                            MID1IP1      MID1 interacting protein 1                                                                           2.18
                        AJ819252                            MKI67IP      MKI67 (FHA domain) interacting nucleolar phosphoprotein                                              2.29
                        AJ673531                              NDP        Norrie disease                                                                                       3.44
                        AM037100                             NUPR1       nuclear protein 1                                                                                    2.27
                        CO888501                             PDPK1       3-phosphoinositide dependent protein kinase-1                                                        2.45
                        AM030492                            PPP1R9B      protein phosphatase 1, regulatory (inhibitor) subunit 9B                                             2.63
                        CO890613                             RAB43       RAB43, member RAS oncogene family                                                                    2.29
                        AJ813402                             SETD7       SET domain containing (lysine methyltransferase) 7                                                   2.40
                        AJ813146                             SNRPG       small nuclear ribonucleoprotein polypeptide G                                                        2.73
                        CO886482                            SLC3A2       solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2           2.54
                        CO892251                            SLC7A8       solute carrier family 7 (cationic amino acid transporter, y + system), member 8                      4.39
                        CO890843                             STOM        stomatin                                                                                             3.65
                        CO880484                             SNTA1       syntrophin, alpha 1                                                                                  4.49
                        CO887666                            UTP14A       UTP14, U3 small nucleolar ribonucleoprotein, homolog A                                               2.26
                  **SA24T0 \> EC24T0**                                                                                                                                
                        CO889600                             AMOT        angiomotin                                                                                           2.12
                        CO889378                             CNN1        calponin 1, basic, smooth muscle                                                                     2.49
                        CN822971                             CALR        calreticulin                                                                                         2.36
                        BF604066                             CD74        CD74 molecule, major histocompatibility complex, class II invariant chain                            2.43
                        CO888048                            CXCL12       chemokine (C-X-C motif) ligand 12                                                                    3.23
                        CO202183                             FEZ1        fasciculation and elongation protein zeta 1                                                          3.13
                        CO873026                             FLNA        filamin A, alpha                                                                                     2.31
                        AJ692384                             GLMN        glomulin, FKBP associated protein                                                                    2.01
                        CN824202                             GSK3B       glycogen synthase kinase 3 beta                                                                      2.02
                        CO887046                            LRRC4C       leucine rich repeat containing 4C                                                                    2.92
                        CO872154                             LASP1       LIM and SH3 protein 1                                                                                2.09
                        AM025652                            MRPL32       mitochondrial ribosomal protein L32                                                                  2.06
                        CO893984                             MYO9B       myosin IXB                                                                                           4.03
                        CO889939                             MYH11       myosin, heavy chain 11, smooth muscle                                                                2.70
                        AM018723                             PIGR        polymeric immunoglobulin receptor                                                                    2.03
                        AJ687977                            SEC24D       SEC24 related gene family, member D                                                                  2.02
                        CO894656                             SENP2       SUMO1/sentrin/SMT3 specific peptidase 2                                                              3.32
                        CO876411                             THY1        Thy-1 cell surface antigen                                                                           2.10
                        pTGFB1\*                             TGFB1       transforming growth factor beta 1                                                                    2.32
                        AJ814326                            B4GALT1      UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase polypeptide 1                                     2.45
                        AM033343                              VIM        vimentin                                                                                             2.36
                        CO880794                             WIPF1       WAS/WASL interacting protein family, member 1                                                        2.34
                 **RESPONSE TO STRESS**                                                                                                                               
                  **EC24T0 \> SA24T0**                                                                                                                                
                        AM006216                             ATF4        activating transcription factor 4                                                                    2.07
                        CN821828                              AGT        angiotensinogen                                                                                      3.73
                        BF076579                              BAX        BCL2-associated X protein                                                                            2.02
                        AJ818096                             CEBPG       CCAAT/enhancer binding protein (C/EBP), gamma                                                        2.19
                        BF606419                             CXCL2       chemokine (C-X-C motif) ligand 2                                                                     2.03
                        CO889145                             CSDA        cold shock domain protein A                                                                          3.16
                        CN824732                             EIF1        eukaryotic translation initiation factor 1                                                           2.08
                        CO892245                            GADD45G      growth arrest and DNA-damage-inducible, gamma                                                        2.91
                        AJ818246                             HSPD1       heat shock 60 kDa protein 1                                                                          2.34
                        CN824191                           HSP90AB1      heat shock protein 90 kDa alpha (cytosolic), class B member 1                                        2.25
                        AJ818172                             HIF1A       hypoxia-inducible factor 1, alpha subunit                                                            2.41
                        AM013900                              LBP        lipopolysaccharide binding protein                                                                   2.79
                        CO888501                             PDPK1       3-phosphoinositide dependent protein kinase-1                                                        2.45
                        CN823413                             SEPP1       selenoprotein P, plasma, 1                                                                           2.12
                        CO886480                             STAT3       signal transducer and activator of transcription 3                                                   2.25
                        AM025615                             TRIB3       tribbles homolog 3                                                                                   3.02
                  **SA24T0 \> EC24T0**                                                                                                                                
                        CO888048                            CXCL12       chemokine (C-X-C motif) ligand 12                                                                    3.23
                        CO883340                              CFD        complement factor D                                                                                  2.31
                        CN824202                             GSK3B       glycogen synthase kinase 3 beta                                                                      2.02
                        AJ820250                             IDH1        isocitrate dehydrogenase 1 (NADP+), soluble                                                          3.36
                        CO886661                            RECQL5       RecQ protein-like 5                                                                                  2.60
                        CO887968                             TYMS        thymidylate synthetase                                                                               3.35
                        AJ695939                             TFPI2       tissue factor pathway inhibitor 2                                                                    2.03
                        pTGFB1\*                             TGFB1       transforming growth factor beta 1                                                                    2.32
                        AJ814326                            B4GALT1      UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase polypeptide 1                                     2.45
                       **DEATH**                                                                                                                                                 
                  **EC24T0 \> SA24T0**                                                                                                                                
                        CN821828                              AGT        angiotensinogen                                                                                      3.73
                        BG693016                             BTG1        B-cell translocation gene 1, anti-proliferative                                                      2.67
                        BF076579                              BAX        BCL2-associated X protein                                                                            2.02
                        AJ818096                             CEBPG       CCAAT/enhancer binding protein (C/EBP), gamma                                                        2.19
                        CO888526                             EMP1        epithelial membrane protein 1                                                                        2.30
                        CO892245                            GADD45G      growth arrest and DNA-damage-inducible, gamma                                                        2.91
                        AJ818246                             HSPD1       heat shock 60 kDa protein 1                                                                          2.34
                        AM037100                             NUPR1       nuclear protein 1                                                                                    2.27
                        CO883017                             PHLPP       PH domain and leucine rich repeat protein phosphatise                                                2.26
                        CO885391                            TAX1BP1      Tax1 (human T-cell leukemia virus type I) binding protein 1                                          3.05
                        AM025615                             TRIB3       tribbles homolog 3                                                                                   3.02
                  **SA24T0 \> EC24T0**                                                                                                                                
                        CN822971                             CALR        calreticulin                                                                                         2.36
                        BF604066                             CD74        CD74 molecule, major histocompatibility complex, class II invariant chain                            2.43
                        pCSF2\*                              CSF2        colony stimulating factor 2 (granulocyte-macrophage)                                                 2.57
                        CN824202                             GSK3B       glycogen synthase kinase 3 beta                                                                      2.02
                        pTGFB1\*                             TGFB1       transforming growth factor beta 1                                                                    2.32
                        AJ814326                            B4GALT1      UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase polypeptide 1                                     2.45
                  **CELL ACTIVATION**                                                                                                                                 
                  **EC24T0 \> SA24T0**                                                                                                                                
                        CN821828                              AGT        angiotensinogen                                                                                      3.73
                        BF076579                              BAX        BCL2-associated X protein                                                                            2.02
                        AJ818096                             CEBPG       CCAAT/enhancer binding protein (C/EBP), gamma                                                        2.19
                  **SA24T0 \> EC24T0**                                                                                                                                
                        BF604066                             CD74        CD74 molecule, major histocompatibility complex, class II invariant chain                            2.43
                        pCSF2\*                              CSF2        colony stimulating factor 2 (granulocyte-macrophage)                                                 2.57
                        AJ692384                             GLMN        glomulin, FKBP associated protein                                                                    2.01
                        CO876411                             THY1        Thy-1 cell surface antigen                                                                           2.10
                        pTGFB1\*                             TGFB1       transforming growth factor beta 1                                                                    2.32

A single accession number is listed for genes represented by multiple clones. Average fold differences were calculated when multiple clones represented a transcript. \* pTGFB1 and pCSF2 are amplicons generated specifically for the Bov20K cDNA microarray.

Closer analysis of the gene list revealed that several genes previously associated with the mammary gland response to bacterial infection are differentially expressed between SA24T0 and EC24T0. These include signal transducer and activator of transcription 3 (STAT3), LBP, CXCL2, BCL2-associated X protein (BAX), B-cell translocation gene 1 (BTG1), metallothioneins and LCN2, which are all expressed at higher levels in EC24T0 samples. This suggests that the EC24T0 samples are responding to infection of neighbouring udder quarters and this accounts for the majority of the transcriptional differences observed between the control quarters.

The DEG were further analyzed using the Ingenuity Pathway Analysis (IPA) software (V7.0, Ingenuity Systems) as described previously \[[@B21]\]. The most striking functional network found to be over-represented in the DEG list involved transforming growth factor beta 1 (TGFB1) and associated molecules (Figure [2](#F2){ref-type="fig"}). Of the 23 genes in this network that were in the DEG list, 17 were expressed at higher levels in SA24T0 samples than EC24T0 samples. It is unclear if this is due to up-regulation of these genes in SA24T0 or down-regulation in EC24T0, but the involvement of TGFB1 in immunosuppression suggests that regulation of these genes may have a profound effect on the ability of the mammary gland quarter to respond to infection.

![**TGFB1 Nework.**Ingenuity pathway analysis of the EC24T0 v SA24T0 DEG list identified an interaction network involving TGFB1 and associated molecules with a network score of 38. Green denotes molecules that were expressed at higher levels in SA24T0 samples and red denotes those more highly expressed in EC24T0 samples.](1471-2164-14-36-2){#F2}

Validation of microarray results comparing EC24T0 and SA24T0
------------------------------------------------------------

Ten genes that exhibited differential expression between EC24T0 and SA24T0 were chosen for validation studies by quantitative RT-PCR (RT-qPCR). Analysis of the microarray results suggested that five of these genes; BTG1, CXCL2, FKBP5, LBP and LCN2, were expressed at higher levels in EC24T0 samples. The RT-qPCR results for all five genes were statistically significant and agreed with the microarray results (Figure [3](#F3){ref-type="fig"}). The other five genes; ATP-binding cassette, sub-family G (WHITE), member 2 (ABCG2), CXCL12, isocitrate dehydrogenase 1 (NADP+), soluble (IDH1), TGFB1 and xanthine dehydrogenase (XDH), were chosen from those that exhibited greater expression in SA24T0 than EC24T0 samples. The RT-qPCR analysis revealed that all five are expressed at statistically significantly higher levels in SA24T0 than EC24T0 samples (Figure [3](#F3){ref-type="fig"}), including ABCG2 which was expressed on average 20.9 fold higher levels in SA24T0 than EC24T0 samples.

![**Validation of EC24T0 v SA24T0 differentially expressed genes.**Summary of the quantitative RT-PCR (RT-qPCR) results for ten selected genes that were identified from the microarray data analysis as exhibiting differential expression between the control quarters from *E. coli*(EC24T0) and *S. aureus*(SA24T0) infected cattle. The results are represented as the average mRNA level detected in EC24T0 (grey bars) and SA24T0 (white bars) relative to the sample with the lowest expression. The bars denote standard error of the mean, \*, \*\* and \*\*\* denote that the expression difference is statistically significant with *P* \< 0.05, *P* \< 0.005 and *P* \< 0.0005 respectively.](1471-2164-14-36-3){#F3}

Genes exhibiting differential expression in control quarters from animals infected with *S. aureus* for 24 and 72 hours
-----------------------------------------------------------------------------------------------------------------------

To confirm that the variation between udder quarters was due only to events occurring in EC24T0, the transcriptome of SA24T0 was compared with that of the control quarters from the 72 hours *S. aureus* infection (SA72T0). No clones exhibited differential expression using a *FDR* less than 0.05. However, using less stringent statistical analyses revealed 115 clones that exhibited differential expression (*P* value ≤ 0.01, fold difference ≥ 2), which are listed in Additional file [2](#S2){ref-type="supplementary-material"}. Eighty one of these clones are annotated, representing 76 genes. Twenty two annotated genes (24 clones) were expressed at significantly higher levels in SA72T0. The remaining 54 annotated genes (57 clones), over two thirds of the differentially expressed genes, were expressed at significantly higher levels in SA24T0. The clone exhibiting the highest expression level compared to SA72T0 represents the cell surface marker CD4, with 4.5 fold higher expression. This suggests that the cellular composition of the control udder quarters differed depending on the time of infection of neighbouring quarters. SOD2, which was identified in the earlier analysis as an up-regulated gene during *S. aureus* infection, was expressed 2.3 fold higher in SA24T0 than SA72T0. Similarly, other genes associated with the mammary gland response to infection are expressed at higher levels in SA24T0, e.g. S100A8, S100A12, CXCL10, interleukin (IL) 1B and lactotransferrin (LTF).

Gene enrichment analysis using DAVID revealed that several GO Biological Process terms are over-represented in the DEG list (Table [3](#T3){ref-type="table"}). The GO term exhibiting the greatest enrichment was Response to Stress. Other over-represented GO terms include; Cell Proliferation, Cell Development, Immune Response and Defence Response. The majority of genes associated with these GO terms are expressed at higher levels in SA24T0 samples. Furthermore, subsequent IPA analysis revealed that the DEG list contained 21 genes that are involved in the functional network with the pro-inflammatory cytokine IL1 at its hub and 17 of these were expressed at higher levels in SA24T0 than SA72T0 samples (Figure [4](#F4){ref-type="fig"}). These results suggest that uninfected quarters respond to the infection of neighbouring quarters with *S. aureus* for at least 24 hours, but this response had waned by 72 hours post infection. Therefore, of the three sets of control samples generated in this study the transcriptome of SA72T0 samples most closely resembles that of an uninfected quarter. This explains the low number of DEG identified in the initial analysis of the transcriptional response of infected quarters to infection (Table [1](#T1){ref-type="table"}). The EC24T0 and SA24T0 samples were used as the baseline to identify DEG, but the response of these quarters to the infection of neighbouring quarters was sufficient to mask the transcriptional response of the infected quarters.

###### 

**Major gene ontology biological process classifications represented by genes differentially expressed between control quarters from cows infected with*S. aureus*for 24 hours (SA24T0) and 72 hours (SA72T0)**

   **Clone accession no.**   **Gene symbol**  **gene**                                                                  **Fold Difference**
  ------------------------- ----------------- ------------------------------------------------------------------------ ---------------------
   **RESPONSE TO STRESS**                                                                                              
    **SA24T0 \> SA72T0**                                                                                               
          CO891789                ASF1A       ASF1 anti-silencing function 1 homolog A                                         2.53
          pCXCL10\*              CXCL10       chemokine (C-X-C motif) ligand 10                                                3.28
          AJ693004               CYP11A1      cytochrome P450, family 11, subfamily A, polypeptide 1                           2.03
          AM018876                 FGA        fibrinogen alpha chain                                                           2.03
           pIL1B\*                IL1B        interleukin 1, beta                                                              2.72
          AM037229                PENK        proenkephalin                                                                    2.23
          BM256666               S100A8       S100 calcium binding protein A8 (calgranulin A)                                  2.19
          BF655078               S100A12      S100 calcium binding protein A12 (calgranulin C)                                 2.29
          AM031467                SOD2        superoxide dismutase 2, mitochondrial                                            2.30
          CO875497               TP53BP1      tumor protein p53 binding protein 1                                              2.68
          AM022673                XRCC2       X-ray repair complementing defective repair in Chinese hamster cells 2           3.22
    **SA72T0 \> SA24T0**                                                                                               
          CK847668                BRCA2       breast cancer 2, early onset                                                     3.47
   **CELL PROLIFERATION**                                                                                              
    **SA24T0 \> SA72T0**                                                                                               
          AM009066                ACSL6       acyl-CoA synthetase long-chain family member 6                                   3.27
          pCXCL10\*              CXCL10       chemokine (C-X-C motif) ligand 10                                                3.28
          CO874867                CSRP2       cysteine and glycine-rich protein 2                                              2.26
          AM018876                 FGA        fibrinogen alpha chain                                                           2.03
           pIL1B\*                IL1B        interleukin 1, beta                                                              2.72
          AM024609                STIL        SCL/TAL1 interrupting locus                                                      2.69
    **SA72T0 \> SA24T0**                                                                                               
          CK847668                BRCA2       breast cancer 2, early onset                                                     3.47
          BI680983                INHA        inhibin, alpha                                                                   2.63
          AJ815547                 IL7        interleukin 7                                                                    3.38
    **CELL DEVELOPMENT**                                                                                               
    **SA24T0 \> SA72T0**                                                                                               
          AM009066                ACSL6       acyl-CoA synthetase long-chain family member 6                                   3.27
          CO874867                CSRP2       cysteine and glycine-rich protein 2                                              2.26
          BM256725                GZMH        granzyme H                                                                       2.35
           pIL1B\*                IL1B        interleukin 1, beta                                                              2.72
          CO887046               LRRC4C       leucine rich repeat containing 4C                                                2.46
          AM031467                SOD2        superoxide dismutase 2, mitochondrial                                            2.30
          CO892784                ZEB2        zinc finger E-box binding homeobox 2                                             2.84
    **SA72T0 \> SA24T0**                                                                                               
          AJ817391                AFF4        AF4/FMR2 family, member 4                                                        3.20
          CK847668                BRCA2       breast cancer 2, early onset                                                     3.47
          BI680983                INHA        inhibin, alpha                                                                   2.63
          AJ815547                 IL7        interleukin 7                                                                    3.38
     **IMMUNE RESPONSE**                                                                                               
    **SA24T0 \> SA72T0**                                                                                               
          AM011262                CTSG        cathepsin G                                                                      2.09
          BF706666                 CD4        CD4 molecule                                                                     4.50
          pCXCL10\*              CXCL10       chemokine (C-X-C motif) ligand 10                                                3.28
          pFCGR3A\*              FCGR3A       Fc fragment of IgG, low affinity IIIa, receptor (CD16)                           3.09
          AM023116                GBP4        guanylate binding protein 4                                                      2.16
           pIL1B\*                IL1B        interleukin 1, beta                                                              2.72
          AM011258                 LTF        lactotransferrin                                                                 3.48
    **SA72T0 \> SA24T0**                                                                                               
          AJ815547                 IL7        interleukin 7                                                                    3.38
    **DEFENSE RESPONSE**                                                                                               
    **SA24T0 \> SA72T0**                                                                                               
          pCXCL10\*              CXCL10       chemokine (C-X-C motif) ligand 10                                                3.28
           pIL1B\*                IL1B        interleukin 1, beta                                                              2.72
          AM011258                 LTF        lactotransferrin                                                                 3.48
          AM037229                PENK        proenkephalin                                                                    2.23
          BM256666               S100A8       S100 calcium binding protein A8 (calgranulin A)                                  2.19
          BF655078               S100A12      S100 calcium binding protein A12 (calgranulin C)                                 2.29

A single accession number is listed for genes represented by multiple clones. Average fold differences were calculated for superoxide dismutase 2, mitochondrial and lactotransferrin, which are represented by multiple clones. \* pCXCL10, pFCGR3A and pIL1B are amplicons generated specifically for the Bov20K cDNA microarray.

![**IL1 Network.**Ingenuity pathway analysis of the SA24T0 v SA72T0 DEG list identified an interaction network involving the pro-inflammatory cytokine IL1 with a network score of 42. Red denotes molecules that were expressed at higher levels in SA24T0 samples and green denotes those more highly expressed in SA72T0 samples.](1471-2164-14-36-4){#F4}

Validation of microarray results comparing SA24T0 and SA72T0
------------------------------------------------------------

The validity of the DEG identified from the comparison of SA24T0 and SA72T0 using less stringent statistical analysis was investigated by RT-qPCR analysis of the expression levels of six genes in the RNA samples. Analysis of the microarray results suggested that CD4 was the most highly expressed gene in SA24T0 compared to SA72T0. However, the RT-qPCR revealed the opposite pattern of expression, with 2.1 fold higher levels in SA72T0 samples (*P* \< 0.005) (Figure [5](#F5){ref-type="fig"}A). Furthermore, mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (MGAT1), which according to the microarray analysis was the most highly expressed gene in SA72T0 compared to SA24T0, exhibited no differential expression by RT-qPCR analysis (Figure [5](#F5){ref-type="fig"}A). However, frequently rearranged in advanced T-cell lymphomas (FRAT1) and LTF exhibited the same pattern of expression by RT-qPCR and microarray analyses. FRAT1 was expressed at on average 2.9 fold higher levels in SA72T0 samples (*P* \< 0.05), whilst LTF was expressed at on average 2.4 fold higher levels in SA24T0 samples (*P* \< 0.05) (Figure [5](#F5){ref-type="fig"}A). Furthermore, although S100A8 and S100A12 did not exhibit statistically significant differential expression by RT-qPCR analysis, the results followed the same trend as observed with the microarray results, with 2.7 fold and 3.6 fold higher expression in SA24T0 samples respectively (Figure [5](#F5){ref-type="fig"}A). The disparity between the microarray and RT-qPCR analyses may relate to the use of different RNA samples from the same udder quarters suggesting that there are localized differences in the response to infection of neighbouring quarters. Alternatively, the disparity may be due to the small number of out-bred animals used in this study.

![**Validation of SA24T0 v SA72T0 differentially expressed genes.**Summary of the quantitative RT-PCR (RT-qPCR) results for selected genes between the control quarters of animals infected with *S. aureus*for 24 hours (SA24T0) or 72 hours (SA72T0). The results are represented as the average mRNA level detected in SA24T0 (white bars) and SA72T0 (grey bars) relative to the sample with the lowest expression. The bars denote standard error of the mean, \* and \*\* denote that the expression difference is statistically significant with *P* \< 0.05 and *P* \< 0.005 respectively. A. RT-qPCR results for six selected genes that were identified from the microarray data analysis as exhibiting differential expression between SA24T0 and SA72T0. B. RT-qPCR results comparing the differential expression of ABCG2, CXCL12, IDH1, TGFB1 and XDH between SA24T0 and SA72T0 samples.](1471-2164-14-36-5){#F5}

In addition, the gene expression of the ten genes used to validate the microarray results for the comparison of EC24T0 and SA24T0 were also measured in the SA72T0 samples. No significant difference in expression was observed in the five genes more highly expressed in EC24T0 samples than SA24T0 samples (data not shown). However, four of the five genes more highly expressed in SA24T0 than EC24T0 samples were found to be more highly expressed in SA72T0 than SA24T0 samples and three showed statistical significance (Figure [5](#F5){ref-type="fig"}B). None of these four genes were identified from the microarray analysis comparison of SA24T0 and SA72T0. Levels of ABCG2, CXCL12 and IDH1 were all statistically significantly higher in SA72T0 than SA24T0 samples, with on average 1.9, 2.3 and 2.0 fold greater expression. Although not statistically significant XDH was on average 2.2 fold higher in SA72T0 compared to SA24T0 samples (*P* = 0.053). In contrast, TGFB1 levels were higher in SA24T0 samples compared to SA72T0 samples, albeit not to a statistically significant level. Therefore, although not in complete agreement with the microarray data, the RT-qPCR results confirm that the transcriptional profiles of uninfected mammary gland quarters differ during the course of *S. aureus* infection of neighbouring quarters.

Discussion
==========

Studies involving farm animals require the use of a large number of animals to obtain statistically meaningful data because these out-bred populations exhibit considerable genetic variation. Therefore, it is appealing to use intra-animal controls where possible, since this reduces genetic variation and fewer biological replicates are required. The quarters of the bovine mammary gland have been considered as separate physiological entities and therefore the use of one or more quarters as controls is a generally accepted experimental design \[[@B3]-[@B7],[@B11]-[@B16]\]. However, the results reported here demonstrate that the mammary gland quarters are interdependent during infection, with a profound change in the transcriptome of one quarter when neighbouring quarters are infected with *S. aureus* and especially *E. coli*. The control quarters remained bacteriologically negative throughout the study period \[[@B10]\] and therefore the observed differences are not due to contamination. The transcriptional response of the uninfected quarters was sufficiently high that it resulted in the masking of the response in infected quarters, when they were used as the base-line for DEG analysis (Table [1](#T1){ref-type="table"}). In contrast, previous studies investigating the bovine mammary gland response to infection which have used within-animal controls have identified large numbers of differentially expressed genes \[[@B4]-[@B7]\]. However, in the earlier studies the animals were only challenged once, whilst in this study the animals were inoculated three times over 24 hours, which may have resulted in a greater signal triggering the response in the uninfected quarters.

Although a direct comparison between uninfected quarters from healthy and uninfected animals was not made in this study, the effect of infection in neighbouring quarters can be inferred from the differences observed between the various control samples. Recently, a microarray experiment comparing the transcriptome of uninfected quarters from healthy and *E. coli* infected animals was reported \[[@B17]\]. A total of 476 DEG were identified, confirming that *E. coli* infection alters the transcriptional response of neighbouring mammary gland quarters. Over twenty eight percent (53) of the DEG identified in our comparison of *E. coli* and *S. aureus* control quarters were also found in this study, which utilized the bovine Affymetrix platform, including ABCG2 and FKBP5. The direction of the transcriptional change observed in these 53 genes was the same in both studies, i.e. those up-regulated during *E. coli* infection of neighbouring quarters \[[@B17]\] were found at higher levels in EC24T0 samples than SA24T0 samples, suggesting that the differential expression of at least these 53 genes is associated with *E. coli* infection and not *S. aureus* infection. The broader intensity plots of the EC24T0 samples illustrated that there was a greater range of transcriptional change in these samples compared to the reference than observed in the SAT0 samples. This may suggest that the vast majority of the differential expression is due to the *E. coli* infection of neighbouring quarters. Furthermore, the transcriptome of the uninfected quarters was indistinguishable from that of quarters infected with *E. coli* for six hours.

However, the design of the experiment reported here does not allow us to conclusively say that the transcriptional differences are all due to changes in expression in the *E. coli* control quarters. Indeed, the comparison of control quarters from animals infected with *S. aureus* for 24 and 72 hours has revealed that *S. aureus* also induces transcriptional changes in neighbouring quarters 24 hours post infection, which may account for some of the differences observed between SA24T0 and EC24T0. Furthermore, XDH, which is involved in the generation of the bactericidal agent peroxynitrate and is believed to play an important role in the mammary gland immune response (reviewed by \[[@B22]\]), is expressed at significantly higher levels in SA24T0 than EC24T0 and therefore may be induced during *S. aureus* infection of neighbouring quarters. Moreover, additional evidence that *S. aureus* infection induces a response in neighbouring quarters has recently been reported. The expression of the acute phase proteins serum amyloid A3 (SAA3) and haptoglobin (HP) as well as the β-defensin DEFB5 was elevated in uninfected control quarters from animals infected with a low virulence strain of *S. aureus* compared to tissue from healthy animals \[[@B23]\].

The initial statistical analysis of the microarray data comparing the *S. aureus* control quarters from the different time courses failed to detect any significantly differentially expressed genes. Although this could be a genuine result, *S. aureus* infection generally induces a milder immune response than *E. coli*, modulating gene expression to a lesser extent at the site of infection, which would impact on the signals being detected by the neighbouring quarters. This variation, compounded with the well-known fact that individual cattle differ greatly in their response to udder infections (reviewed by \[[@B24]\]), would result in considerable variability in the response of neighbouring quarters to *S. aureus* infection and could account for the lack of statistical significance, which would be further exacerbated by the low number of biological replicates included in this study. Indeed, lowering the stringency of the microarray analysis allowed the identification of over 70 genes, including several genes known to be associated with the mammary gland response to infection, e.g. SOD2, IL1B, LTF, S100A8 and S100A12. Nearly one sixth of the differentially expressed genes are associated with the response of cells to stress. Furthermore, IPA revealed that a network of IL1 and associated molecules were expressed at higher levels in SA24T0 samples than in the SA72T0 samples, which are a well-known trigger for inflammation. Paradoxically, the cattle infected with *S. aureus* did not show signs of inflammation, even in the infused udder quarters, 24 hours post infection \[[@B10]\], when the elevated levels of IL1 and related molecules were detected in this study. Conversely, at 72 hours, when the IL1 response was lower in uninfected quarters, the infected quarters showed up-regulation of inflammation-associated genes \[[@B10]\]. Therefore, *S. aureus* infection may initially elicit a slight systemic inflammatory response that induces IL1 expression in uninfected quarters, which disappears during sustained infection. It is unclear if *S. aureus* actively contributes to the down-regulation of the systemic response, which may contribute to the typically sub-clinical disease pattern observed in *S. aureus* mastitis.

Some of the transcriptional changes may relate to changes in the cellular composition of the mammary gland. Bacterial infections induce the influx of immune cells, predominantly neutrophils, into the infected mammary gland quarter, which leads to increasing SCC in milk. The SCC measured in the control quarters from animals included in this study increased during the time course of both *E. coli* and *S. aureus* infection \[[@B10]\]. This is in agreement with previous studies which found significantly higher SCC in milk from uninfected quarters of naturally infected animals compared to those from healthy animals \[[@B25]-[@B27]\]. Moreover, the percentage of neutrophils was significantly higher, whilst the percentage of macrophages was significantly lower, in milk from uninfected quarters from animals with mastitis compared to those from healthy animals \[[@B27]\]. Differential expression of cell surface markers, e.g. CD74, Fc receptors and CD4, are indicative of differences in the cellular composition of the control quarters from *E. coli* and *S. aureus* infected animals. Levels of CD4^+^ T lymphocytes increase in milk during *S. aureus* infection \[[@B26],[@B28]\] and the results reported here suggest that some cells may originate from the uninfected quarters.

The influx of immune cells may not account for all the transcriptional changes of uninfected quarters. The response of the first quarter to infection with *E. coli* was significantly different from that of the second infected quarter after the same period of infection. The profound increase in SCC observed in milk from the first quarter 12 hours post infection was not observed in milk samples from the second quarter infected 12 hours later \[[@B10]\]. The earlier infection appears to have primed the neighbouring mammary gland quarters to respond differently to infection. Similar results have been reported recently in an experimental infection study where one animal showed signs of infection in one udder quarter before the experiment started \[[@B7]\]. This animal was still included in the study, using the other, uninfected udder quarters. The proinflammatory cytokine response, i.e. up-regulation of IL1B, IL6, IL8 and tumour necrosis factor (TNF), of this animal was more pronounced than that observed in other animals included in the study \[[@B7]\]. The priming of the mammary gland may persist after infection. Experimental *E. coli* infection of individual quarters fourteen days after infection of neighbouring quarters resulted in significantly less bacteria being isolated from the milk than observed with the initial infection \[[@B29]\]. Furthermore, it was recently reported that priming udders with a low dose of *E. coli* lipopolysaccharide (LPS) protects against experimental infection with *E. coli* pathogens \[[@B30]\]. Moreover, LPS priming induces sustained expression of bactericidal factors (e.g. β-defensins) by bovine mammary epithelial cells (MEC), whilst reducing the over expression of pro-inflammatory cytokines which may be harmful to the animal \[[@B31]\]. However, there is little overlap in DEG from primed MEC and those observed in the uninfected quarters included in this study, suggesting that different mechanisms may be involved in priming neighbouring quarters.

TGFB1 levels were observed to be much lower in the control quarters from *E. coli* infected animals than those from animals infected with *S. aureus*. Therefore, it is interesting to hypothesize that the priming of the udder quarters involves the suppression of levels of TGFB1 and associated molecules which was revealed by IPA. Moreover, the same pattern of TGFB3 expression has previously been reported using the same experimental samples \[[@B32]\]. The TGFBs are pleiotropic cytokines which play an important role in multiple biological processes including regulating the adaptive and innate immune responses. TGFB1 inhibits inflammation by, amongst other mechanisms, suppressing the activation of several immune cells, e.g. NK cells and macrophages, and although chemotactic, can inhibit neutrophil transmigration (reviewed by \[[@B33]\]). Further analysis has shown that significantly lower levels of TGFB1 mRNA is present in the uninfected quarters of *E. coli* infected animals included in this study than in the quarters of healthy animals involved in another study \[[@B17]\] (Additional file [3](#S3){ref-type="supplementary-material"}). It appears that animals down regulate the expression of TGFB1 in the udder when a neighbouring quarter has been challenged with *E. coli* pathogens. This reduction in the level of the immunosuppressor TGFB1 would lower the threshold for triggering the induction of a variety of immunologically relevant genes, resulting in a faster and more robust response to infection. In contrast, the weaker stimulus elicited by invading *S. aureus* pathogens maintains, or possibly enhances (Additional file [3](#S3){ref-type="supplementary-material"}), the relatively high levels of TGFB1 present in uninfected quarters, thereby buffering immune stimuli in the healthy, uninfected udder quarter.

Response to Stress was one of the major GO Biological Processes categories identified in both the comparisons of EC24T0 and SA24T0 and that of *S. aureus* control quarters. Many of the genes within this category have previously been identified as being involved in the immune response to mastitis, including LBP, STAT3, S100A8 and SOD2. However, many of the most differentially regulated genes, e.g. ABCG2 and FKBP5, have not, to our knowledge, previously been associated with mastitis. Both ABCG2 and FKBP5 were also identified as DEG in the recent transcriptional comparison of uninfected quarters from healthy and mastitic animals \[[@B17]\], suggesting that their differential expression was due to the infection of neighbouring quarters with *E. coli*. Furthermore, the expression of both genes was modulated in *E. coli* infected mammary gland quarters \[[@B17]\].

ABCG2, also known as breast cancer resistance gene (BCRP), is a xenobiotic transporter that is expressed at high levels in lactating mammary glands of cows, humans and mice \[[@B34],[@B35]\]. ABCG2 plays an important role in the transport of nutrients into milk, especially riboflavin (vitamin B~2~) \[[@B36]\] and has been identified as the candidate gene underlying a quantitative trait locus on bovine chromosome 6 that affects milk yield and composition \[[@B37],[@B38]\]. Therefore, the down-regulation of ABCG2 in quarters neighbouring *E. coli* infected quarters may be associated with the decrease in milk yield and casein synthesis, which was observed in these animals \[[@B10],[@B39]\] and may imply a nutrient deficiency in milk from these animals.

The immunophilin FKBP5 has several functions, including mediating the action of the immunosuppressive drug FK506. The FKBP5-FK506 complex binds protein phosphatase 3, catalytic subunit, alpha isozyme (PPP3CA), also known as calcineurin, thus preventing it from phosphorylating and activating NFAT transcription factors, which in turn prevents T cell activation and proliferation \[[@B40]\]. FKBP5 is highly expressed in murine T cells \[[@B40]\] and therefore the up-regulation observed during *E. coli* infection may be due to lymphocyte migration into mammary gland tissue. In addition, FKBP5 is induced by glucocorticoids and is believed to be involved in the negative feedback loop for glucocorticoid receptor signalling \[[@B41]\]. FKBP5, along with heat shock protein 90 (HSP90), is a component of the glucocortcoid receptor complex. The HSP90 family member HSP90AB1 exhibits a similar expression profile as FKBP5 in both this study and Mitterheumer et al. \[[@B17]\]. Glucocorticoids are able to modulate NF-κB activity by a FKBP5-dependent pathway \[[@B42]\]. FKBP5 interacts with conserved helix-loop-helix ubiquitous kinase (IKKα), which phosphorylates nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IκBα), the inhibitor of NF-κB, resulting in IκBα proteosome-mediated degradation and the nuclear translocation and activation of NF-κB \[[@B43]\].

The mechanism by which the infection of neighbouring quarters affects the transcriptome of uninfected quarters is unknown. Mastitis induces a systemic effect, inducing transcriptional changes in the liver \[[@B44]\], including the production of acute phase proteins which are released into the blood that circulates around all the udder quarters. This has been postulated to explain the transcriptional profile in healthy quarters of animals infected with *E. coli*\[[@B17]\]. Furthermore, it has become clear that endogenous damage or danger signals \[[@B45]\] also lead to inflammation \[[@B46]\] and evidence now supports their role in the response to pathogens \[[@B47]\]. Therefore, it is possible that the uninfected udder quarters are responding to such danger or damage signals released into the extracellular environment following infection in the neighbouring quarters. However, analysis of TLR and β-defensin expression in the local and peripheral lymph nodes of animals included in this study revealed that a response was only observed in the lymph nodes draining the quarters infected with *E. coli* for 12 and 24 hours \[[@B10]\], suggesting that the systemic effect is quite limited. Local cross-talk between the udder quarters must, therefore, be responsible for priming the neighbouring udder quarters. Indeed, lymphocytes have been shown to be capable of migrating between mammary gland quarters \[[@B48]\] and therefore the presence of a more localized interaction between quarters is probable and requires further investigation.

Conclusions
===========

It has previously been shown that during *E. coli* infection the immune status of neighbouring, sterile quarters is modified \[[@B17]\]. The results presented here provide further evidence of this and also illustrate that a similar phenomenon occurs during *S. aureus* infection. However, the details of the transcriptional response induced by these pathogens appear to be quite distinct, but are difficult to separate out fully in this study due to the experimental design used. However, the data suggest that the induced transcriptional changes prime the uninfected quarters to prevent or limit the spread of infection. The outcome of mastitis infections is influenced by multiple factors, including the virulence of the pathogen and host genetics. It is clear that the previous exposure of animals to pathogens is also important. Considering the frequency of mastitic infections on dairy farms the pathogen primed state may be the predominant status of uninfected quarters and therefore worthy of further investigation. Furthermore, the results described here illustrate that the four quarters of the bovine mammary gland cannot be considered as separate experimental units during infection studies. This has important ramifications for the design of experimental challenge studies, as the use of inappropriate controls can result in the masking of transcriptional changes during infection. Therefore caution should be taken when using within-animal controls.

Methods
=======

Experimental design of the infection study
------------------------------------------

The design of the infection study has been described in detail previously in accordance with ARRIVE guidelines \[[@B10]\]. This work was carried out under the approval of the ethics committee of the regional government in Hannover, Germany (No. 509.6-42502-03**/**678). Briefly, twelve Holstein cows in the middle of their first lactation were challenged over 24 or 72 hours with 500 cfu *E. coli* strain 1303 or 10,000 cfu *S. aureus* strain 1027. The animals were randomly divided into three groups. Four animals were inoculated intramammary with *E. coli* in the front right, hind right and hind left udder quarters at 0 (T24), 12 (T12) and 18 (T6) hours after the trial started respectively. The front left quarter received 2 ml sterile saline at the start of the experiment. The animals were euthanized after 24 hours, with a penetrating captive bolt gun followed by exsanguination, and tissue samples were collected asceptically from each udder quarter. The second group of four animals were inoculated with *S. aureus* over the same 24 hour period. The third group of four animals were inoculated with *S. aureus* in both right quarters (T72) and inoculated with 2 ml sterile saline in the front left quarter at 0 hours. The hind left quarter was inoculated at 60 hours (T12) after the start of the experiment. The cows were euthanized after 72 hours as described above and tissue samples were collected from each udder quarter. The control quarters from animals in these three groups are referred to as EC24T0, SA24T0 and SA72T0 respectively in this paper. All animals infected with *E. coli* developed acute mastitis within 12 hours, although the major clinical symptoms, e.g. udder swelling and elevated SCC, where only observed in the inoculated mammary gland quarters \[[@B10]\]. In contrast, clinical signs of mastitis were only observed in animals infected with *S. aureus* for 72 hours \[[@B10]\].

RNA samples
-----------

A 5 cm^3^ tissue sample were removed asceptically from the inner area of each udder quarter, 10 cm dorsal of the milk cistern, within 5--10 minutes of culling. A small section of the centre of this sample (1.0 x 0.5 x 0.5 cm) was stored in RNAlater (Ambion) for RNA isolation. Total RNA was extracted as described previously \[[@B49]\] by caesium chloride gradient followed by phenol/chloroform extraction and sodium acetate precipitation. One hundred micrograms of each RNA sample was purified further using RNeasy mini columns (Qiagen) using the manufacturer's protocols. The quality and quantity of the resulting RNA was determined by gel electrophoresis and Agilent 2100 Bioanalyzer.

Microarray experiment
---------------------

### Experimental design

The RNA samples from each mammary gland quarter were analyzed separately and hybridized in competition with a pooled reference sample, made up of all the RNA samples. A common reference design was used to allow the multifactorial analysis of the complete experiment. The reference sample was labelled with cyanine (Cy) 3 and the treatment sample with Cy5 on each microarray slide. The microarray experiment therefore consisted of a total of 48 microarray slides. The microarray data has been submitted to ArrayExpress and assigned the accession number E-TABM-704.

### RNA labelling & hybridizations

Fluorescently labelled cDNA was generated from 20 μg total RNA using the FairPlay II microarray labelling kit (Stratagene), following the manufacturer's protocol. The labelled cDNA was purified using a DyeEx spin column (Qiagen) and the labelling efficiency was determined by running 0.5 μl of each sample on a 1% agarose gel. Labelled cDNA was hybridized onto the ARK-Genomics *Bos taurus* 20 K v1.0 microarray (ArrayExpress accession no. A-MEXP-1402). Hybridizations were carried out in a GeneTac automated hybridization station (Genomic Solutions) to control for reactions conditions and washing of the arrays. The Cy3 and Cy5 labelled cDNA were mixed and added to 125 μl hybridization solution (ARK-Genomics protocols: <http://www.ark-genomics.org>) and hybridized onto the microarray for 12 hours. The microarray slides were then washed in wash buffers of increasing stringency (Genomic Solutions). After removal from the hybridization station the microarray slides were sequentially washed in post-wash buffer and isopropanol for one minute before being dried by centrifugation at 220 *g* for six minutes. The dried slides were scanned in a Scanarray 5000 XL scanner (GSI Lumonics) at constant laser power of 75% and 73% for Cy3 and Cy5 respectively.

### Data analysis

Microarray spot intensity and quality data were extracted from the scanned images using the BlueFuse software version II (BlueGnome). Preliminary analysis was carried out using the GeneSpring software package (Agilent). Further analysis was carried out using modifications of the Limma package of Bioconductor \[[@B50]\], with additional plotting from the Marray package. The microarray data exhibited low signal to noise ratios, which resulted in excessive variability at low intensity values. To reduce this each channel was augmented by 256. The normalization and analysis steps were weighted using the BlueFuse quality measure, confidence values between 0 and 1 \[[@B51]\], and manually excluded spots were given the minimum confidence value. Each slide was normalized separately, using the log~2~-ratios of treatment to reference intensities for all the non-control spots. The data was normalized using a 2-step process of spatial followed by intensity dependent bias correction for each print-tip, as described previously \[[@B52]\]. The spatial bias was corrected by subtracting corresponding row and column means from each spot \[[@B53]\]. The intensity dependent bias was removed by block-lowess \[[@B54]\].

Genes that were differentially expressed between the infected and control samples were identified by analyzing the means of replicate spots. The Limma eBayes correction \[[@B55]\] was used to shrink the residual variances of each gene towards their median value. Comparisons between the infected and control samples were assessed by 1-way ANOVA followed by *t-*tests. *FDR* values for each comparison were calculated using the method of Benjamini and Hochberg \[[@B56]\]. Genes with *FDR* values less than or equal to 0.05 were considered as significantly different. To refine the list of differentially expressed genes further to those of probable biological relevance, only those genes exhibiting a 2 fold or greater average difference were considered.

Validation of microarray experiments
------------------------------------

RT-qPCR analysis was used to validate the microarray results for sixteen differentially expressed genes. Oligonucleotides were designed for each gene using Primer3 \[[@B57]\] and Netprimer (Biosoft International) software (Table [4](#T4){ref-type="table"}). Total RNA was isolated from a different sample of mammary gland tissue than that used for the microarray experiment. The tissue was powdered under liquid nitrogen and mixed with the chaotropic RLT lysis buffer (Qiagen). RNA was extracted with Phenol (Ambion) and purified using RNeasy spin columns (Qiagen) including a DNase digestion step (Qiagen) according to the manufacturer's instructions. The RNA quality was assessed by agarose gel electrophoresis and NanoDrop ND-1000 spectrophotometer (Thermo Scientific).

###### 

Details of the oligonucleotides used for the quantitative RT-PCR analysis

  **Gene**                                    **Gene Symbol**   **Direction**  **Sequence (5′-3′)**       **Product size**
  ------------------------------------------ ----------------- --------------- ------------------------- ------------------
  ATP-binding cassette, sub-family G               ABCG2              F        CCTTCGGCTTCCAACAACT              129
  (WHITE), member 2                                                   R        CCAGACACACCACGGATAAA               
  B-cell translocation gene 1, anti-               BTG1               F        TGAAAGTAGCAAGTGACCAGAA           192
  proliferative                                                       R        CAAGGAGAGTTACAAACCAGACC            
  CD4 molecule                                      CD4               F        GGCAGAACCACAGACTCACA             133
                                                                      R        GACAAACAAGCCCAAAGGAA               
  Chemokine (C-X-C motif) ligand 2                 CXCL2              F        GCCAAACCGAAGTCATAGCC             213
                                                                      R        TGGAAACCAGCCATTCTCTTC              
  Chemokine (C-X-C motif) ligand 12               CXCL12              F        TTGAAAGCCTGACCCATAAA             146
                                                                      R        GACAGTGGCAGCAGAGAAG                
  FK506 binding protein 5                          FKBP5              F        CCACAGCAGCATCACACAC              189
                                                                      R        GGGAAGGCTAATCCAGAACC               
  Frequently rearranged in advanced T-             FRAT1              F        GCCCAAAGGACAAGGATG               186
  cell lymphomas                                                      R        CCAAGAACAAGCACCTCAAA               
  Isocitrate dehydrogenase 1 (NADP+),              IDH1               F        CTCTCAAGGGTAAAGGCAAA             113
  soluble                                                             R        TTCACAAAGGTGGCATAACTG              
  Lactotransferrin                                  LTF               F        CTGTGGCTAAATTCTTCTCTGC           187
                                                                      R        TTAACAAAAGCCACGTCTCCAG             
  Lipocalin 2                                      LCN2               F        CCAACTACGAGCTGAAGGAAGAC          103
                                                                      R        TGGGAGCTTGGGACAAAAGT               
  Lipopolysaccharide binding protein                LBP               F        AGGGCAAGGTGAAAGACAGG             178
                                                                      R        TGGAGTCAGAGAGGGTGTGG               
  Mannosyl (alpha-1,3-)-glycoprotein beta-         MGAT1              F        TCTCCATCCAGTCCTTTCCA             191
  1,2-N-acetylglucosaminyltransferase                                 R        ACATTGCTCTCCAACCCATC               
  S100 calcium binding protein A8                 S100A8              F        TCTATTTTGGGGAGACCTGGTG           203
                                                                      R        CCAAGTGTCCGCATCCTTTT               
  S100 calcium binding protein A12                S100A12             F        AGGGAATCATCAACATCTTCCAC          172
                                                                      R        TCTTTATCGGCATCCAGGTCTT             
  Transforming growth factor, beta 1               TGFB1              F        AATGGTGGAATACGGCAACA             121
                                                                      R        CCGAGAGAGCAACACAGGTTC              
  Xanthine dehydrogenase                            XDH               F        TCAGGATGATGGTTGGAAGA             193
                                                                      R        GGGAGTTAGGACATAGCACGA              
  Chromosome alignment maintaining                CHAMP1              F        AGCAGTGACCAAGAGCAGGT             205
  phosphoprotein 1                                                    R        TCATAGCACGACAGCAACAA               

F and R denote forward and reverse primers respectively.

The RT-qPCRs for twelve genes were carried out as described previously \[[@B58]\]. The relative quantities of mRNA were calculated using the method described by Pfaffl \[[@B59]\]. The RT-qPCR results for chromosome alignment maintaining phosphoprotein 1 (CHAMP1) were used to calculate differences in the template RNA levels and thereby standardize the results for the genes of interest. The RT-qPCR for the remaining four genes; chemokine (C-X-C motif) ligand (CXCL) 2, lipocalin 2 (LCN2), S100 calcium bind proteins (S100) A8 and S100A12, were carried out as described previously \[[@B60]\] and relative copy numbers were calculated. These results were converted to fold differences to standardize the results for all sixteen genes. All samples were measured twice from two independent cDNA preparations. The quality and authenticity of the resulting RT-qPCR products were assessed by agarose gel electrophoresis and sequencing. The relative quantity values were transformed on the log~2~ scale before statistical analyses to stabilize the variance and make them comparable to the log (intensity ratios) from the microarray analysis. The effect of infection in neighbouring quarters was examined by *t*-test analysis (Genstat 8.1, Lawes Agricultural Trust, Rothamsted).
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###### Additional file 1

**List of clones exhibiting statistically significant differential expression between control quarters from*E. coli*and*S. aureus*infected cows.**An excel file listing the 255 clones, representing 187 known genes, exhibiting differential expression between control quarters from *E. coli* and *S. aureus*infected cows (fold difference ≥ 2, *FDR*\< 0.05). The fold differences between the control quarters from *E. coli*(EC24T0) and *S. aureus*(SA24T0) infected cattle are displayed as a positive number when EC24T0\>SA24T0 (highlighted in orange) and a negative number when SA24T0\>EC24T0 (highlighted in green). Genes shown in bold are represented by more than one clone. The calculated *FDR*values are included.

###### 

Click here for file

###### Additional file 2

**List of clones exhibiting statistically significant differential expression between control quarters from cows infected with*S. aureus*for 24 and 72 hours.**An excel file listing the 115 clones, representing 76 known genes, exhibiting differential expression between control quarters from cows infected with *S. aureus*for 24 (SA24T0) and 72 hours (SA72T0) (fold difference ≥ 2, *P*\< 0.01). The fold differences between the control quarters from animals infected with *S. aureus*for 24 hours (SA24T0) or 72 hours (SA72T0) are displayed as a positive number when SA24T0\>SA72T0 (highlighted in orange) and a negative number when SA72T0\>SA24T0 (highlighted in green). Genes shown in bold are represented by more than one clone. The calculated *P*values are included.

###### 

Click here for file

###### Additional file 3

**Infection of neighbouring quarters affects the levels of TGFB1 mRNA in uninfected quarters.**Comparison of TGFB1 mRNA levels in uninfected quarters of cattle infected for 24 hours with *S. aureus*(SA24T0), *E. coli*(EC24T0) or from healthy, uninfected (HEALTHY) cattle. TGFB1 levels are expressed as relative copy numbers and the bars denote standard error of the mean. The statistical significance is indicated as P values and n.s. denotes not significant. The HEALTHY samples were included in a previously published study \[[@B17]\]. Animals in both studies were selected using the same criteria and hormonally synchronized using the same procedure.
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